Peyronie's disease: review and recent advances

Maturitas. 2014 Aug;78(4):341-3. doi: 10.1016/j.maturitas.2014.05.024. Epub 2014 Jun 6.

Abstract

Peyronie's disease is an incurable, sexually debilitating fibrotic disease of the penis that results in penile curvature, coital failure, and significant psychological stress for patients and their partners. Appropriate treatment should be individualized and tailored to the patient's goals and expectations, disease history, physical exam findings, and erectile function. While medical treatments exist, there is little evidence to support their use. High-quality data supporting more recent advances in injectable therapies, interferon α-2b and collagenase clostridium histolyticum, show great promise for their application. Once the disease has stabilized, surgical correction is also an excellent option for patients with significant Peyronie's disease accompanied by functional impairment. Outcomes are satisfactory when proper treatment decisions are made, with the goal being expected return to normal sexual function following treatment.

Keywords: Erectile dysfunction; Penile curvature; Penile plaque; Peyronie's disease.

Publication types

  • Review

MeSH terms

  • Erectile Dysfunction / etiology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Microbial Collagenase / therapeutic use*
  • Penile Induration / complications
  • Penile Induration / drug therapy*
  • Penile Induration / surgery
  • Penis / pathology*
  • Recombinant Proteins / therapeutic use

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Microbial Collagenase